Lv21
140 积分 2025-03-05 加入
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
2个月前
已完结
Improving IBD outcomes in the era of many treatment options
2个月前
已完结
Ulcerative colitis
2个月前
已完结
Targeting KRAS in cancer
3个月前
已完结
皖公网安备34019202002308
